Oorsprong van het eerstegraads netwerk van David W. Pritchard
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 20 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met David W. Pritchard via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Sales & Marketing General Counsel Corporate Officer/Principal General Counsel | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| INTERMUNE INC | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| SYNTARA LIMITED | Pharmaceuticals: Major | Chairman | |
Signature Therapeutics, Inc.
 Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Signature Therapeutics, Inc. develops and manufactures pharmaceutical products. It focuses on developing medications for use in pain management and ADHD. Its proprietary BIO-MD platform is designed to deter prescription drug abuse by virtue of strong chemical bonds within the prodrug and also offers solution to the ongoing epidemic of prescription opioid drug abuse. The company was founded by Steven L. Shafer in 2004 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | General Counsel | |
Viveve, Inc.
 Viveve, Inc. Medical SpecialtiesHealth Technology Viveve, Inc. engages in the development of medical devices that promote personal health and wellness. It offers InControl products and Viveve system solutions. The company was founded by Jonathan B. Parmer in 2005 and is headquartered in Englewood, CO. | Medical Specialties | Chairman | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Undergraduate Degree | |
| AFFYMAX, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
Covance Biotechnology Services, Inc.
 Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Covance Biotechnology Services, Inc. develops pharmaceutical products. The company offers two microbiology laboratories, one for mycoplasma analysis, and a second for molecular biology. It provides services to biomolecules, including recombinant proteins, monoclonal antibodies, vaccines, blood products, and gene therapy products. The company was founded by Richard J. Hawkins, V. Bryan Lawlis, and John A. Scarlett in 1995 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
GBS Venture Partners Pty Ltd.
 GBS Venture Partners Pty Ltd. Investment ManagersFinance GBS Venture Partners Pty Ltd (GBS Venture Partners) is a venture capital firm founded in 1996 by Helen Brigitte Smith and Geoff E.D Brooke. The firm is headquartered in Melbourne. | Investment Managers | Founder | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Masters Business Admin Undergraduate Degree | |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Undergraduate Degree | |
| Rensselaer Polytechnic Institute | College/University | Doctorate Degree Doctorate Degree | |
| San Francisco State University | College/University | Masters Business Admin | |
| University of Birmingham | College/University | Undergraduate Degree Undergraduate Degree | |
| PDL BIOPHARMA, INC. | Biotechnology | Comptroller/Controller/Auditor Director/Board Member | |
Neuromonics, Inc.
 Neuromonics, Inc. Medical SpecialtiesHealth Technology Neuromonics, Inc. manufactures and distributes medical devices for long-term relief of tinnitus. The firm offers Neuromonics tinnitus treatment which is used for the treatment of tinnitus. The company was founded by Paul B. Davis in 2001 and is headquartered in Westminster, CO. | Medical Specialties | Director/Board Member | |
Cortical Pty Ltd.
 Cortical Pty Ltd. BiotechnologyHealth Technology Cortical Pty Ltd. discovers and develops medical drugs for the treatment of inflammatory and proliferative diseases. The company was founded in 2003 by Eric F. Morand and Magdy N. Iskander and is headquartered in Clayton, Australia. | Biotechnology | Director/Board Member | |
Avillion LLP
 Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Theravance Biopharma US, Inc.
 Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Yale School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
ReForm Biologics LLC
 ReForm Biologics LLC BiotechnologyHealth Technology ReForm Biologics LLC develops formulation technologies for biotherapeutics molecules. It provides technologies that include Viscosity-reducing excipients, Stability-enhancing excipients, and Surfactant-replacing excipients. The company was founded by David S. Soane and Zachariah Jonasson and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| CYTOMX THERAPEUTICS, INC. | Pharmaceuticals: Major | Public Communications Contact | |
| ABSCI CORPORATION | Biotechnology | Director/Board Member | |
Tspan LLC
 Tspan LLC Pharmaceuticals: MajorHealth Technology Tspan LLC is an American pharmaceutical manufacturing company. The private company is based in New York. | Pharmaceuticals: Major | Director/Board Member | |
Itero Holdings LLC
 Itero Holdings LLC Financial ConglomeratesFinance Itero Holdings LLC provides investment services. The private company is based in San Jose, CA. | Financial Conglomerates | Chief Executive Officer | |
| STRUCTURE THERAPEUTICS INC. | Miscellaneous Commercial Services | Director/Board Member | |
Comera Life Sciences, Inc.
 Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | Pharmaceuticals: Major | Director/Board Member | |
| COMERA LIFE SCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Kalobios Pharmaceuticals, Inc. | Director/Board Member Director/Board Member | ||
| GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 43 |
| Australië | 7 |
| Verenigd Koninkrijk | 3 |
Sectoraal
| Health Technology | 34 |
| Consumer Services | 8 |
| Commercial Services | 4 |
| Distribution Services | 3 |
| Finance | 3 |
Operationeel
| Director/Board Member | 118 |
| Independent Dir/Board Member | 50 |
| Corporate Officer/Principal | 43 |
| Chief Tech/Sci/R&D Officer | 19 |
| Undergraduate Degree | 17 |
Sterkste connecties
| Insiders | |
|---|---|
| Ted Love | 31 |
| Brigitte Smith | 28 |
| Dennis J. Henner | 26 |
| V. Lawlis | 21 |
| Gary Lyons | 20 |
| Laurie Alsup | 14 |
| Herbert Cross | 14 |
| Jonathan Leff | 14 |
| Denise M. Gilbert | 11 |
| Jeanne Jew | 11 |
| Jeffrey Cooper | 11 |
| Carmen Betancourt | 11 |
| Néstor A. Molfino | 10 |
| Thomas C. Yonker | 10 |
| Donald Joseph | 9 |
- Beurs
- Insiders
- David W. Pritchard
- Bedrijfsconnecties
